Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: The Tromsø study

European Journal of Endocrinology

Volumn 162, Issue 5, 2010, Pages 935-942

  Hutchinson, Moira Strand ^a   Grimnes, Guri ^b   Joakimsen, Ragnar Martin ^a,b   Figenschau, Yngve ^a,b   Jorde, Rolf ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOASSAY; LIFESTYLE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NORWAY; RISK; RISK FACTORS; SMOKING; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77951656788     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-1041     Document Type: Article

References (46)

1. Holick MF. Vitamin D deficiency. New England Journal of Medicine 2007 357 266-281.
2. Maalouf NM. The noncalciotropic actions of vitamin D: recent clinical developments. Current Opinion in Nephrology and Hypertension 2008 17 408-415.
3. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T & Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. American Journal of Clinical Nutrition 2006 84 18-28.
4. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocrine Reviews 2001 22 477-501.
5. Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J, Knol DL & Lips P. Vitamin D status predicts physical performance and its decline in older persons. Journal of Clinical Endocrinology and Metabolism 2007 92 2058-2065.
6. Melamed ML, Michos ED, PostW& Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Archives of Internal Medicine 2008 168 1629-1637.
7. Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002 94 1867-1875.
8. Grant WB & Garland CF. The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Research 2006 26 2687-2699.
9. Porojnicu AC, Dahlback A & Moan J. Sun exposure and cancer survival in Norway: changes in the risk of death with season of diagnosis and latitude. Advances in Experimental Medicine and Biology 2008 624 43-54.
10. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G & Maerz W. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Archives of Internal Medicine 2008 168 1340-1349.
11. Pilz S, Dobnig H, Nijpels G, Heine RJ, Stehouwer CD, Snijder MB, van Dam RM & Dekker JM. Vitamin D and mortality in older men and women. Clinical Endocrinology 2009 71 666-672.
12. Semba RD, Houston DK, Bandinelli S, Sun K, Cherubini A, Cappola AR, Guralnik JM & Ferrucci L. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. European Journal of Clinical Nutrition 2010 64 203-209.
13. Giovannucci E, Liu Y, Hollis BW & Rimm EB. 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Archives of Internal Medicine 2008 168 1174-1180.
14. Kilkkinen A, Knekt P, Aro A, Rissanen H, Marniemi J, Heliovaara M, Impivaara O & Reunanen A. Vitamin D status and the risk of cardiovascular disease death. American Journal of Epidemiology 2009 170 1032-1039.
15. Kuroda T, Shiraki M, Tanaka S & Ohta H. Contributions of 25-hydroxyvitamin D, co-morbidities and bone mass to mortality in Japanese postmenopausal women. Bone 2009 44 168-172.
16. Autier P & Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Archives of Internal Medicine 2007 167 1730-1737.
17. Thelle DS, Foorde OH, Try K & Lehmann EH. The Tromso Heart Study. Methods and main results of the cross-sectional study. Acta Medica Scandinavica 1976 200 107-118.
18. Jorde R & Bonaa KH. Calcium from dairy products, vitamin D intake, and blood pressure: the Tromso Study. American Journal of Clinical Nutrition 2000 71 1530-1535.
19. Holick MF. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. Journal of Investigative Dermatology 1981 77 51-58.
20. Hollis BW. Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. American Journal of Clinical Nutrition 2008 88 507S-510S.
21. Grant WB & Garland CF. A critical review of studies on vitamin D in relation to colorectal cancer. Nutrition and Cancer 2004 48 115-123.
22. McLaughlin M, Raggatt PR, Fairney A, Brown DJ, Lester E & Wills MR. Seasonal variations in serum 25-hydroxycholecalciferol in healthy people. Lancet 1974 1 536-538.
23. Harris SS & Dawson-Hughes B. Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. American Journal of Clinical Nutrition 1998 67 1232-1236.
24. Melin A, Wilske J, Ringertz H & Saaf M. Seasonal variations in serum levels of 25-hydroxyvitamin D and parathyroid hormone but no detectable change in femoral neck bone density in an older population with regular outdoor exposure. Journal of the American Geriatrics Society 2001 49 1190-1196. (Pubitemid 32900146)
25. Cigolini M, Iagulli MP, Miconi V, Galiotto M, Lombardi S & Targher G. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 2006 29 722-724. (Pubitemid 44115386)
26. Kim DH, Sabour S, Sagar UN, Adams S & Whellan DJ. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). American Journal of Cardiology 2008 102 1540-1544.
27. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M & Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008 117 503-511.
28. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R & Norris K. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine 2007 167 1159-1165. (Pubitemid 46919818)
29. Pilz S, Dobnig H, Fischer JE, Wellnitz B, Seelhorst U, Boehm BO & Marz W. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 2008 39 2611-2613.
30. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC & Curhan GC. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007 49 1063-1069. (Pubitemid 351664326)
31. Scragg R, Sowers M & Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. American Journal of Hypertension 2007 20 713-719. (Pubitemid 46936167)
32. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Progress in Biophysics and Molecular Biology 2006 92 39-48. (Pubitemid 43831966)
33. Rostand SG & Drueke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney International 1999 56 383-392. (Pubitemid 29353135)
34. Saleh FN, Schirmer H, Sundsfjord J & Jorde R. Parathyroid hormone and left ventricular hypertrophy. European Heart Journal 2003 24 2054-2060. (Pubitemid 37420453)
35. Hagstrom E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundstrom J, Melhus H, Held C, Lind L, Michaelsson K & Arnlov J. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009 119 2765-2771.
36. Li YC. Vitamin D regulation of the renin-angiotensin system. Journal of Cellular Biochemistry 2003 88 327-331.
37. Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, Liu W, Li X, Gardner DG & Li YC. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. American Journal of Physiology. Endocrinology and Metabolism 2005 288 E125-E132. (Pubitemid 40023798)
38. Hansson GK, Libby P, Schonbeck U & Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circulation Research 2002 91 281-291. (Pubitemid 34976993)
39. Saggese G, Federico G, Balestri M & Toniolo A. Calcitriol inhibits the PHA-induced production of IL-2 and IFN-gamma and the proliferation of human peripheral blood leukocytes while enhancing the surface expression of HLA class II molecules. Journal of Endocrinological Investigation 1989 12 329-335. (Pubitemid 19155179)
40. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR & Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. American Journal of Clinical Nutrition 2007 85 1586-1591. (Pubitemid 46890428)
41. Giovannucci E. Vitamin D and cancer incidence in the Harvard cohorts. Annals of Epidemiology 2009 19 84-88.
42. Robsahm TE, Tretli S, Dahlback A & Moan J. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes and Control 2004 15 149-158. (Pubitemid 38445361)
43. Lim HS, Roychoudhuri R, Peto J, Schwartz G, Baade P & Moller H. Cancer survival is dependent on season of diagnosis and sunlight exposure. International Journal of Cancer 2006 119 1530-1536. (Pubitemid 44258757)
44. Pilz S, Tomaschitz A, Obermayer-Pietsch B, Dobnig H & Pieber TR. Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Research 2009 29 3699-3704.
45. Scragg R & Camargo CA Jr. Frequency of leisure-time physical activity and serum 25-hydroxyvitamin D levels in the US population: results from the Third National Health and Nutrition Examination Survey. American Journal of Epidemiology 2008 168 577-591.
46. Visser M, Deeg DJ, Puts MT, Seidell JC & Lips P. Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. American Journal of Clinical Nutrition 2006 84 616-622. (Pubitemid 44713413)